Competitors: | Trellus Health, Open Orphan , Mediclinic International , Cambridge Cognition Holdings, Sourcebio International, Sensyne Health, CareTech Holding, Diaceutics |
CEO: | Paul Christopher Swinney |
Executive Director: | Bart Leemans |
Finance Director: | Elizabeth Dixon |
Independent Non-Executive Director: | Isabel J S Napper |
Independent Non-Executive Director: | Caroline Stephens |
Non-Executive Chairman: | Bruno Holthof |
Senior Independent Non-Executive Director: | Tom Jenkins |
Non-Executive Dir: | David Orr |
Address: | Unit 1B Lynx Business Park, Fordham Road, Snailwell, Newmarket, Cambridgeshire , United Kingdom, CB8 7NY |
Phone: | 44 (0) 1638 721500 |
Fax: | 44 (0) 1638 721911 |
Website: | http://www.tristel.com |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00B07RVT99 |
Currency | UK Pounds |
Share Price | 410.00p |
Change Today | -20.00p |
% Change | -4.65 % |
52 Week High | 445.00 |
52 Week Low | 295.00 |
Volume | 52,116 |
Shares Issued | 47.31m |
Market Cap | £193.98m |
Beta | 0.04 |
RiskGrade | 180 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 0 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 16-Mar-23 | 17-Nov-22 |
Paid | 11-Apr-23 | 16-Dec-22 |
Amount | 2.62p | 3.93p |
Time | Volume / Share Price |
16:14 | 254 @ 405.11p |
16:11 | 11,406 @ 410.00p |
16:08 | 940 @ 405.00p |
15:42 | 90 @ 405.11p |
15:28 | 96 @ 409.90p |
CEO | Paul Christopher Swinney |
Finance Director | Elizabeth Dixon |
You are here: research